Purity 98%: Asparaginase with 98% purity is used in acute lymphoblastic leukemia chemotherapy, where high purity ensures maximum enzymatic activity for efficient asparagine depletion.

Molecular Weight 136 kDa: Asparaginase with molecular weight 136 kDa is used in pediatric oncology protocols, where its molecular profile reduces immunogenic response.

Enzymatic Activity 10,000 IU/mg: Asparaginase with enzymatic activity of 10,000 IU/mg is used in antineoplastic therapy, where high activity accelerates asparagine hydrolysis and improves therapeutic outcomes.

Stability Temperature 4°C: Asparaginase stable at 4°C is used in hospital storage conditions, where low-temperature stability preserves enzyme functionality during long-term storage.

Lyophilized Form: Asparaginase in lyophilized form is used in intravenous administration, where enhanced shelf-life and reconstitution flexibility optimize dosing schedules.

Endotoxin Level <0.1 EU/mg: Asparaginase with endotoxin level below 0.1 EU/mg is used in parenteral formulations, where minimized endotoxin content reduces risk of adverse immune reactions.

Isoelectric Point pH 5.1: Asparaginase with isoelectric point at pH 5.1 is used in biopharmaceutical formulations, where optimized charge properties facilitate improved solubility and stability.

Particle Size <50 µm: Asparaginase with particle size less than 50 micrometers is used in injectable preparations, where fine particle distribution ensures rapid dissolution and homogeneous mixing.

Residual DNA <10 ng/mg: Asparaginase with residual DNA content below 10 ng/mg is used in clinical bioprocessing, where low genetic impurities ensure high patient safety.

Immunogenicity Profile Reduced: Asparaginase with reduced immunogenicity profile is used in repeated administration regimens, where lower immunogenicity decreases allergic reaction incidence.